Insights On Partnering

31. Clinical, Commercial Packaging: Delivering Next-Gen Therapies 4/7/2026

    See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

32. Accelerate Drug Development With Master Protocols 5/15/2025

    Through careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.

33. When Vendor Disruption Threatens Trial Timelines: What Sponsors Should Do Next 9/30/2026

    When vendors face disruptions, trials can be affected. Discover key questions to assess partner stability, strengthen operational resilience, and keep studies on track.

34. FastChain®: A Solution For Made-To-Order Gene Replacement Therapy Study 3/12/2026

    Adopt a demand-led clinical supply strategy to reduce waste, optimize limited product supply, and accelerate patient access across global clinical trials.

35. Harness An Adept IRB's Expertise To Streamline Study Design 10/2/2026

    An Institutional Review Board protects human research participants by evaluating study ethics, consent, and risks, while providing sponsors with ongoing guidance on complex trial protocols.

36. Comparator Selection And Supply: Best Practices For Clinical Success 3/25/2026

    Explore best practices for comparator selection and supply optimization in clinical trials, including sourcing strategies, risk mitigation, regulatory compliance, and real-world cost-saving case studies.

37. The Power Of Us: Commitment To Patients And Customers 10/23/2026

    Four customer-facing commitments, from preventing randomization delays to reducing ad hoc requests, define accountability in trial technology and keep every build connected to a patient hoping for access.

38. Breaking Down Operational And Financial Complexity In Clinical Trials 12/8/2025

    Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.

39. State of Materiovigilance: Gaps, Technology & Outsourcing 5/12/2026

    Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.

40. Optimizing Clinical Supply Management With A One-Team Approach 7/15/2026

    See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.